Psychomotor Agitation
Psychomotor Agitation
Explore linked clinical trials. Standard reference: MESH:M001802339 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease | Alzheimer disease, Dyskinesias, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Psychomotor Agitation, Psychomotor Disorders, Signs and Symptoms, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Recruiting | Phase 3 | 2026-10-08 | NCT07011745 | |
| Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type | Dyskinesias, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Psychomotor Agitation, Psychomotor Disorders, Signs and Symptoms, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, psychiatric disorder | Recruiting | Phase 2 | 2026-10-08 | NCT06052254 | |
| Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease | Alzheimer disease, Dyskinesias, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Psychomotor Agitation, Psychomotor Disorders, Signs and Symptoms, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Recruiting | Phase 2 | 2026-10-06 | NCT06808984 | |
| Decoding Death and Dying in People With Dementia by Digital Thanotyping | Death, Dyskinesias, Neurobehavioral Manifestations, Neurologic Manifestations, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Psychomotor Agitation, Psychomotor Disorders, Respiration Disorders, Respiratory Aspiration, Signs and Symptoms, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, psychiatric disorder, respiratory system disorder | Enrolling by invitation | Not stated | 2026-10-01 | NCT06437132 | |
| Clinical Trial on Agitation in Alzheimer's Dementia | Alzheimer disease, Chemically-Induced Disorders, Dyskinesias, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Psychomotor Agitation, Psychomotor Disorders, Signs and Symptoms, anxiety disorder, brain disorder, cannabis dependence, central nervous system disorder, cognitive disorder, dementia, depressive disorder, nervous system disorder, neurodegenerative disease, psychiatric disorder, substance-related disorder, tauopathy | Active, not recruiting | Phase 2 | 2026-09-30 | NCT05543681 | |
| A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3) | Alzheimer disease, Dyskinesias, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Psychomotor Agitation, Psychomotor Disorders, Signs and Symptoms, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Recruiting | Phase 3 | 2026-09-28 | NCT06937229 | |
| Neurosteer Bedside Monitoring System | Confusion, Dyskinesias, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Psychomotor Agitation, Psychomotor Disorders, Signs and Symptoms, cognitive disorder, delirium, nervous system disorder, psychiatric disorder | Recruiting | Not applicable | 2026-09-28 | NCT06718764 | |
| Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type | Dyskinesias, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Psychomotor Agitation, Psychomotor Disorders, Signs and Symptoms, nervous system disorder | Active, not recruiting | Phase 3 | 2026-09-15 | NCT05397639 | |
| Goal-Directed Sedation in Mechanically Ventilated Infants and Children | Confusion, Critical Illness, Disease Attributes, Dyskinesias, Neurobehavioral Manifestations, Neurologic Manifestations, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Psychomotor Agitation, Psychomotor Disorders, Signs and Symptoms, Stress Disorders, Traumatic, acute stress disorder, cognitive disorder, delirium, nervous system disorder, post-traumatic stress disorder, psychiatric disorder | Active, not recruiting | Phase 3 | 2026-09-11 | NCT04801589 | |
| Safety and Efficacy of Esketamine - Dexmedetomidine Combination Versus Dexmedetomidine Monotherapy for Hyperactive Delirium in ICU Patients on Non-Invasive Respiratory Support (SEED-NIRS Trial): Study Protocol of a Randomized Controlled Trial | Dyskinesias, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Psychomotor Agitation, Psychomotor Disorders, Signs and Symptoms, agnosia, nervous system disorder, perceptual disorders | Not yet recruiting | Phase 4 | 2026-09-03 | NCT07377981 | |
| A Multicomponent Intervention Program to Prevent and Reduce ICU Agitation and Physical Restraint Use | Dyskinesias, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Psychomotor Agitation, Psychomotor Disorders, Signs and Symptoms, nervous system disorder | Recruiting | Not applicable | 2026-08-20 | NCT05783505 | |
| Neural Mechanisms of Clinically Designed Improvisatory Music for Alzheimer's Disease | Alzheimer disease, Dyskinesias, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Psychomotor Agitation, Psychomotor Disorders, Signs and Symptoms, anxiety disorder, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Enrolling by invitation | Not applicable | 2026-08-10 | NCT05477862 | |
| Effect of Daily Screen Time on Postoperative Emergence Delirium in Children Aged 2-11 Years | Dyskinesias, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Psychomotor Agitation, Psychomotor Disorders, Signs and Symptoms, nervous system disorder | Recruiting | Not stated | 2026-08-05 | NCT07552896 | |
| Protocolized Receptive Music Intervention to Reduce Care Refusal in Nursing Home Residents With Major Neurocognitive Disorders | Burnout, Professional, Cognition Disorders, Cognitive Dysfunction, Dyskinesias, Neurobehavioral Manifestations, Neurologic Manifestations, Occupational Diseases, Occupational Stress, Pathological Conditions, Signs and Symptoms, Psychomotor Agitation, Psychomotor Disorders, Signs and Symptoms, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, psychiatric disorder | Recruiting | Not applicable | 2026-07-28 | NCT07730957 | |
| A Computer-Assisted Tool for Objective Assessment of Extrapyramidal Symptoms | Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Dyskinesias, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Psychomotor Agitation, Signs and Symptoms, central nervous system disorder, drug-induced akathisia, drug-induced dyskinesia, movement disorder, nervous system disorder, poisoning, tardive dyskinesia, toxic encephalopathy | Not yet recruiting | Not stated | 2026-07-21 | NCT07715994 | |
| Melatonin for Post Tonsillectomy Emergence Agitation in Pediatric | Dyskinesias, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Psychomotor Agitation, Psychomotor Disorders, Signs and Symptoms, nervous system disorder | Recruiting | Not applicable | 2026-07-17 | NCT07375342 | |
| Virtual Reality to Reduce Anxiety, Agitation and Delirium in Critically Ill Patients | Dyskinesias, Dyssomnias, Neurobehavioral Manifestations, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Psychomotor Agitation, Psychomotor Disorders, Signs and Symptoms, Sleep Disorders, Intrinsic, anxiety disorder, insomnia, nervous system disorder, psychiatric disorder, sleep-wake disorder | Recruiting | Not applicable | 2026-06-22 | NCT07649876 | |
| Human Mesenchymal Stem Cells (hMSC) in Behavioral Problems Due to Alzheimer's Disease. | Alzheimer disease, Dyskinesias, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Psychomotor Agitation, Psychomotor Disorders, Signs and Symptoms, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Recruiting | Phase 2 | 2026-05-28 | NCT06781333 | |
| Clinical Trial of Peer Support in the ED (PCORI) | Dyskinesias, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Psychomotor Agitation, Psychomotor Disorders, Signs and Symptoms, nervous system disorder, psychiatric disorder | Not yet recruiting | Not applicable | 2026-05-18 | NCT06556069 | |
| PARO-agitation-study | Confusion, Dyskinesias, Emergence Delirium, Neurobehavioral Manifestations, Neurologic Manifestations, Pain, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Postoperative Pain, Psychomotor Agitation, Psychomotor Disorders, Signs and Symptoms, anxiety disorder, cognitive disorder, delirium, nervous system disorder, psychiatric disorder | Recruiting | Not applicable | 2026-05-05 | NCT07568093 | |
| A Clinical Trial of Iron Supplementation for Youth With ADHD and Restless Sleep | Dyskinesias, Dyssomnias, Neurobehavioral Manifestations, Neurologic Manifestations, Parasomnias, Pathological Conditions, Signs and Symptoms, Psychomotor Agitation, Psychomotor Disorders, Signs and Symptoms, Sleep Disorders, Intrinsic, attention deficit hyperactivity disorder, inattentive type, nervous system disorder, neurodevelopmental disorder, oppositional defiant disorder, psychiatric disorder, restless legs syndrome, sleep-wake disorder | Not yet recruiting | Phase 1 / Phase 2 | 2026-05-04 | NCT07061470 | |
| Therapeutic Cuddling in Critically Ill Children | Confusion, Dyskinesias, Neurobehavioral Manifestations, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Psychomotor Agitation, Psychomotor Disorders, Signs and Symptoms, cognitive disorder, delirium, nervous system disorder, psychiatric disorder | Recruiting | Not applicable | 2026-05-01 | NCT07562048 | |
| Targeting Brain Physiology to Treat Neuropsychiatric Symptoms of Dementia Using TMS-EEG and tDCS | Alzheimer disease, Dyskinesias, Mixed Dementias, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Psychomotor Agitation, Psychomotor Disorders, Signs and Symptoms, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Active, not recruiting | Not applicable | 2026-04-13 | NCT03846492 | |
| Standardizing Care for Neuropsychiatric Symptoms and Quality of Life in Dementia | Alzheimer disease, Dyskinesias, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Psychomotor Agitation, Psychomotor Disorders, Signs and Symptoms, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Active, not recruiting | Not applicable | 2026-04-13 | NCT03672201 | |
| Activation-Socialization Intervention Program for Seniors | Dyskinesias, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Psychomotor Agitation, Psychomotor Disorders, Signs and Symptoms, anxiety disorder, nervous system disorder, psychiatric disorder | Enrolling by invitation | Not applicable | 2026-04-09 | NCT07498179 |